Company & Sponsor Intelligence

German Center for Neurodegenerative Diseases (DZNE)

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting0

Completed0

Countries1

Therapeutic footprint

alzheimers

Indexed studies

NCT04427436Novel Dementia Biomarkers
alzheimers · UNKNOWN

NCT03056495Clinical Trial to Determine Tolerable Dosis of Vorinostat in Patients With Mild Alzheimer Disease
alzheimers · GermanyPHASE1

NCT05529277Implementing Dementia Care Management Into Routine Care in the Region Siegen-Wittgenstein
alzheimers · GermanyUNKNOWN

Intelligence layer updated: 2026-10-29 23:42:44.865458+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →